Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Infectious Diseases
Published in: BMC Infectious Diseases 1/2016

Open Access 01-12-2016 | Research article

Clinical and epidemiological analysis of Campylobacter fetus subsp. fetus infections in humans and comparative genetic analysis with strains isolated from cattle

Authors: Robert Escher, Colette Brunner, Niklaus von Steiger, Isabelle Brodard, Sara Droz, Carlos Abril, Peter Kuhnert

Published in: BMC Infectious Diseases | Issue 1/2016

Login to get access

Abstract

Background

Campylobacter fetus subspecies fetus (CFF) is an important pathogen for both cattle and humans. We performed a systematic epidemiological and clinical study of patients and evaluated the genetic relatedness of 17 human and 17 bovine CFF isolates by using different genotyping methods. In addition, the serotype, the dissemination of the genomic island containing a type IV secretion system (T4SS) and resistance determinants for tetracycline and streptomycin were also evaluated.

Methods

The isolates from patients diagnosed with CFF infection as well as those from faecal samples of healthy calves were genotyped using pulsed-field gel electrophoresis (PFGE), multilocus sequence typing (MLST), as well as single locus sequence typing (SLST) targeting cmp1 and cmp2 genes encoding two major outer membrane proteins in CFF. The presence of the genomic island and identification of serotype was determined by PCRs targeting genes of the T4SS and the sap locus, respectively. Tetracycline and streptomycin resistance phenotypes were determined by minimal inhibitory concentration. Clinical data obtained from medical records and laboratory data were supplemented by data obtained via telephone interviews with the patients and treating physicians.

Results

PFGE analysis defined two major clusters; cluster A containing 16 bovine (80 %) isolates and cluster B containing 13 human (92 %) isolates, suggesting a host preference. Further genotypic analysis using MLST, SLST as well as sap and T4SS PCR showed the presence of genotypically identical isolates in cattle and humans. The low diversity observed within the cmp alleles of CFF corroborates the clonal nature of this pathogen. The genomic island containing the tetracycline and streptomycin resistance determinants was found in 55 % of the isolates in cluster A and correlated with phenotypic antibiotic resistance.

Conclusions

Most human and bovine isolates were separated on two phylogenetic clusters. However, several human and bovine isolates were identical by diverse genotyping methods, indicating a possible link between strains from these two hosts.
Literature
1.
Skirrow MB. Diseases due to Campylobacter, Helicobacter and related bacteria. J Comp Pathol. 1994;111:113–49.CrossRefPubMed
2.
Tremblay C, Gaudreau C. Antimicrobial susceptibility testing of 59 strains of Campylobacter fetus subsp. fetus. Antimicrob Agents Chemother. 1998;42:1847–9.PubMedPubMedCentral
3.
Gazaigne L, Legrand P, Renaud B, Bourra B, Taillandier E, Brun-Buisson C, Lesprit P. Campylobacter fetus bloodstream infection: risk factors and clinical features. Eur J Clin Microbiol Infect Dis. 2008;27:185–9.CrossRefPubMed
4.
Hagiya H, Matsumoto M, Furukawa H, Murase T, Otsuka F. Mycotic Abdominal Aortic Aneurysm Caused by Campylobacter fetus: A Case Report and Literature Review. Ann Vasc Surg. 1933;2014(28):e7–e14.
5.
Morrison VA, Lloyd BK, Chia JK, Tuazon CU. Cardiovascular and bacteremic manifestations of Campylobacter fetus infection: case report and review. Rev Infect Dis. 1990;12:387–92.CrossRefPubMed
6.
Wagenaar JA, van Bergen MA, Blaser MJ, Tauxe RV, Newell DG, van Putten JP. Campylobacter fetus infections in humans: exposure and disease. Clin Infect Dis. 2014;58:1579–86.CrossRefPubMed
7.
Cypierre A, Denes E, Barraud O, Jamilloux Y, Jacques J, Durox H, Pinet P, Weinbreck P. Campylobacter fetus infections. Med Mal Infect. 2014;44:167–73.CrossRefPubMed
8.
Bessède E, Lehours P, Labadi L, Bakiri S, Mégraud F. Comparison of characteristics of patients infected by Campylobacter jejuni, Campylobacter coli, and Campylobacter fetus. J Clin Microbiol. 2014;52:328–30.CrossRefPubMedPubMedCentral
9.
Pacanowski J, Lalande V, Lacombe K, Boudraa C, Lesprit P, Legrand P, Trystram D, Kassis N, Arlet G, Mainardi JL, Doucet-Populaire F, Girard PM, Meynard JL; CAMPYL Study Group. Campylobacter bacteremia: clinical features and factors associated with fatal outcome. Clin Infect Dis. 2008;47:790–6.CrossRefPubMed
10.
Pigrau C, Bartolome R, Almirante B, Planes AM, Gavalda J, Pahissa A. Bacteremia due to Campylobacter species: clinical findings and antimicrobial susceptibility patterns. Clin Infect Dis. 1997;25:1414–20.CrossRefPubMed
11.
Liao CH, Chuang CY, Huang YT, Lee PI, Hsueh PR. Bacteremia caused by antimicrobial resistant Campylobacter species at a medical center in Taiwan, 1998–2008. J Infect. 2012;65:392–9.CrossRefPubMed
12.
Saito S, Naito T, Kukino J, Okumura T, Sekiya S, Isonuma H, Watanabe K, Dambara T, Hayashida Y. Campylobacter fetus subsp. fetus sepsis: a case report and review of the literatures in Japan. Kansenshogaku Zasshi. 2004;78:70–5.CrossRefPubMed
13.
Tremblay C, Gaudreau C, Lorange M. Epidemiology and antimicrobial susceptibilities of 111 Campylobacter fetus subsp. fetus strains isolated in Québec, Canada, from 1983 to 2000. J Clin Microbiol. 2003;41:463–6.CrossRefPubMedPubMedCentral
14.
van Bergen MA, Dingle KE, Maiden MC, Newell DG, van der Graaf-Van Bloois L, van Putten JP, Wagenaar JA. Clonal nature of Campylobacter fetus as defined by multilocus sequence typing. J Clin Microbiol. 2005;43:5888–98.CrossRefPubMedPubMedCentral
15.
Hurcombe SD, Fox JG, Kohn CW. Isolation of Campylobacter fetus subspecies fetus in a two-year-old quarterhorse with chronic diarrhea of an undetermined etiology. J Vet Diagn Invest. 2009;21:266–9.CrossRefPubMed
16.
Sprenger H, Zechner EL, Gorkiewicz G. So close and yet so far – Molecular Microbiology of Campylobacter fetus subspecies. Eur J Microbiol Immunol. 2012;2:66–75.CrossRef
17.
Cody AJ, Maiden MJ, Dingle KE. Genetic diversity and stability of the porA allele as a genetic marker in human Campylobacter infection. Microbiology. 2009;155:4145–54.CrossRefPubMedPubMedCentral
18.
Cascales E, Christie PJ. The versatile bacterial type IV secretion systems. Nat Rev Microbiol. 2003;1:137–49.CrossRefPubMed
19.
20.
Abril C, Brodard I, Perreten V. Two novel antibiotic resistance genes, tet(44) and ant(6)-Ib, are located within a transferable pathogenicity island in Campylobacter fetus subsp. fetus. Antimicrob Agents Chemother. 2010;54:3052–5.CrossRefPubMedPubMedCentral
21.
Abril C, Vilei EM, Brodard I, Burnens A, Frey J, Miserez R. Discovery of insertion element ISCfe1: a new tool for Campylobacter fetus subspecies differentiation. Clin Microbiol Infect. 2007;13:993–1000.CrossRefPubMed
22.
Fujita M, Fujimoto S, Morooka T, Amako K. Analysis of strains of Campylobacter fetus by pulsed-field gel electrophoresis. J Clin Microbiol. 1995;33:1676–8.PubMedPubMedCentral
23.
Dworkin J, Tummuru MK, Blaser MJ. Segmental conservation of sapA sequences in type B Campylobacter fetus cells. J Biol Chem. 1995;270:15093–101.CrossRefPubMed
24.
Garrow AG, Agnew A, Westhead DR. TMB-Hunt: a web server to screen sequence sets for transmembrane beta-barrel proteins. Nucleic Acids Res. 2005;33(Web Server issue):W188–192.CrossRefPubMedPubMedCentral
25.
26.
Romero Gómez MP, García-Perea A, Ruiz Carrascoso G, Bajo MA, Mingorance J. Campylobacter fetus peritonitis and bacteremia in a patient undergoing continuous ambulatory peritoneal dialysis. J Clin Microbiol. 2010;48:336–7.CrossRefPubMed
27.
Shimizu Y, Ishii A, Takahata A, Kajiyama T, Yamahatsu A, Io H, Kurusu A, Hamada C, Horikoshi S, Tomino Y. Campylobacter bacteremia in hemodialysis patients by eating raw meat - the importance of sanitary education. Case Rep Nephrol Urol. 2012;2:145–51.CrossRefPubMedPubMedCentral
28.
Lee YC, Huang YT, Sheng WH, Hsueh PR. Simultaneous peritoneal dialysis-associated peritonitis and bacteremia due to ceftriaxone-resistant Campylobacter fetus. Perit Dial Int. 2011;31:366–8.CrossRefPubMed
29.
Sui F, Le Dû D, Roux AL, Hanachi M, Dinh A, Crémieux AC. Meningitis and endocarditis caused by Campylobacter fetus after raw-liver ingestion. J Clin Microbiol. 2013;51:3147–50.CrossRef
30.
Tanaka A, Takahashi J, Hirabayashi H, Ogihara N, Mukaiyama K, Shimizu M, Hashidate H, Kato H. A Case of Pyogenic Spondylodiscitis Caused by Campylobacter fetus for Which Early Diagnosis by Magnetic Resonance Imaging Was Difficult. Asian Spine J. 2012;6:274–8.CrossRefPubMedPubMedCentral
31.
Chaillon A, Baty G, Lauvin MA, Besnier JM, Goudeau A, Lanotte P. Campylobacter fetus subspecies fetus spondylodiscitis. J Med Microbiol. 2010;59:1505–8.CrossRefPubMed
32.
Wong JSJ, Anderson TP, Chambers ST, On SLW, Murdoch DR. Campylobacter fetus-associated epidural abscess and bacteremia. J Clin Microbiol. 2009;47:857–8.CrossRefPubMedPubMedCentral
33.
34.
Yamagami K, Miyashita T, Nakamura T, Shirano M, Nakamura T, Kameda K, Nishijima M, Imanishi M, Yang X, Kanegane H. Campylobacter fetus bacteremia with purulent pleurisy in a young adult with primary hypogammaglobulinemia. Intern Med. 2014;53:1221–5.CrossRefPubMed
35.
Decousser JW, Prouzet-Mauléon V, Bartizel C, Gin T, Colin JP, Fadel N, Holler C, Pollet J, Megraud F. Fatal relapse of a purulent pleurisy caused by Campylobacter fetus subsp. fetus. J Clin Microbiol. 2007;45:2334–6.CrossRefPubMedPubMedCentral
36.
Désidéri-Vaillant C, Guichon JM, Noyer V, Nedelec Y, Galinat H, Sapin-Lory J, Di Costanzo L, Le Guen P, Nicolas X. [Campylobacter fetus endocarditis: a case report]. Ann Biol Clin. 2013;71:465–7.
37.
Haruyama A, Toyoda S, Kikuchi M, Arikawa T, Inami S, Otani N, Amano H, Matsuda R, Inoue T. Campylobacter fetus as cause of prosthetic valve endocarditis. Tex Heart Inst J. 2011;38:584–7.PubMedPubMedCentral
38.
Miki K, Maekura R, Hiraga T, Hirotani A, Hashimoto H, Kitada S, Miki M, Yoshimura K, Naka N, Motone M, Fujikawa T, Takashima S, Kitazume R, Kanzaki H, Nakatani S, Watanuki H, Tagusari O, Kobayashi J, Ito M. Infective tricuspid valve endocarditis with pulmonary emboli caused by Campylobacter fetus after tooth extraction. Intern Med. 2005;44:1055–9.CrossRefPubMed
39.
Ledina D, Ivic I, Karanovic J, Karanovic N, Kuzmicic N, Ledina D, Puljiz Z. Campylobacter fetus infection presenting with bacteremia and cellulitis in a 72-year-old man with an implanted pacemaker: a case report. J Med Case Rep. 2012;6:414–6.CrossRefPubMedPubMedCentral
40.
Chambers ST, Morpeth SC, Laird HM. Campylobacter fetus prosthetic hip joint infection: successful management with device retention and review. J Infection. 2005;50:258–61.CrossRef
41.
Kienesberger S, Sprenger H, Wolfgruber S, Halwachs B, Thallinger GG, Perez-Perez GI, Blaser MJ, Zechner EL, Gorkiewicz G. Comparative genome analysis of Campylobacter fetus subspecies revealed horizontally acquired genetic elements important for virulence and niche specificity. PLoS One. 2014;9:e85491.CrossRefPubMedPubMedCentral
42.
Inoue K, Kitamura H, Nagasawa Y, Kawada N, Isaka Y, Rakugi H. Campylobacter fetus peritonitis in a patient with an unused embedded subcutaneous peritoneal catheter. Perit Dial Int. 2010;30:253–4.CrossRefPubMed
43.
Serraino A, Florio D, Giacometti F, Piva S, Mion D, Zanoni RG. Presence of Campylobacter and Arcobacter species in in-line milk filters of farms authorized to produce and sell raw milk and of a water buffalo dairy farm in Italy. J Dairy Sci. 2013;96:2801–7.CrossRefPubMed
44.
Kramer JM, Frost JA, Bolton FJ, Wareing DR. Campylobacter contamination of raw meat and poultry at retail sale: identification of multiple types and comparison with isolates from human infection. J Food Prot. 2000;63:1654–9.CrossRefPubMed
45.
Ichiyama S, Hirai S, Minami T, Nishiyama Y, Shimizu S, Shimokata K, Ohta M. Campylobacter fetus subspecies fetus cellulitis associated with bacteremia in debilitated hosts. Clin Infect Dis. 1998;27:252–5.CrossRefPubMed
46.
Martinez-Balzano C, Kohlitz PJ, Chaudhary P, Hegazy H. Campylobacter fetus bacteremia in a young healthy adult transmitted by khat chewing. J Infection. 2013;66:184–6.CrossRef
Metadata
Title
Clinical and epidemiological analysis of Campylobacter fetus subsp. fetus infections in humans and comparative genetic analysis with strains isolated from cattle
Authors
Robert Escher
Colette Brunner
Niklaus von Steiger
Isabelle Brodard
Sara Droz
Carlos Abril
Peter Kuhnert
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2016
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-016-1538-7

Other articles of this Issue 1/2016

BMC Infectious Diseases 1/2016 Go to the issue

Research article

Seroprevalence of hepatitis C virus among people living with HIV/AIDS in Latin America and the Caribbean: a systematic review

Research article

Prolonged tuberculosis-associated immune reconstitution inflammatory syndrome: characteristics and risk factors

Case report

Coxiella burnetii dormancy in a fatal ten-year multisystem dysfunctional illness: case report

Research article

Re-emergence of H3N2 strains carrying potential neutralizing mutations at the N-linked glycosylation site at the hemagglutinin head, post the 2009 H1N1 pandemic

Research article

Immune recovery in acute and chronic HIV infection and the impact of thymic stromal lymphopoietin

Research article

Mechanisms of first-line antimicrobial resistance in multi-drug and extensively drug resistant strains of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits